← Eichor
Study identifier: NCT06039644 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

To Evaluate the Clinical Efficacy of Probiotics in Patients With the Breast Cancer

Condition: Breast Cancer  ·  Sponsor: GenMont Biotech Incorporation

PhaseNA
Planned participants100
Who can joinAll sexes, 20 Years to 80 Years
Healthy volunteersNo

About this study

Chemotherapy-associated side-effects would affect therapeutic effect, quality of life, and cause permanent harm to breast cancer patients. This study is designed to explore after consumption of probiotics of lactobacillus composite strain powder sachets for 6 months in breast cancer chemotherapy, and whether the improvement of meliorate the side effects, further assists patients completing the chemotherapy.

This description comes directly from the study's public registry record.

Talk to the study team

Fang-Kuei Lin, Master  ·  +886-6-505-2151  ·  meitung@genmont.com.tw

Wan-Hua Tsai, PhD  ·  +886-6-505-2151  ·  twh@genmont.com.tw

Always discuss trial participation with your own doctor first.

Locations (1)

Mackay Memorial HospitalTaipei, TaiwanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06039644